Related Experiment Video
Updated: Feb 4, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Phenotypic variations in carriers of predicted protein-truncating genetic variants in MYBPC3: an autopsy-based case
Nori Williams1, Robert Marion2, Thomas V McDonald3
1Molecular Genetics Laboratory, New York City Office of Chief Medical Examiner, New York City, United States.
Insights
Predicted protein-truncating variants (PTVs) in the MYBPC3 gene were identified in hypertrophic cardiomyopathy (HCM) cases. Cardiac-specific PTVs were associated with earlier death in males compared to non-cardiac PTVs.
Area of Science:
- Cardiovascular Genetics
- Molecular Pathology
- Sudden Cardiac Death Etiology
Background:
- Hypertrophic cardiomyopathy (HCM) is frequently linked to pathogenic variants in the MYBPC3 gene.
- Investigating genetic variants in autopsied cases provides insight into disease mechanisms and mortality.
- Predicted protein-truncating variants (PTVs) represent a significant class of genetic alterations with potential clinical impact.
Observation:
- Four pathogenic PTVs in MYBPC3 were identified in male decedents from autopsied HCM cases.
- Two PTVs were located in the cardiac-specific N-terminal M-motif, and two were in the non-cardiac-specific C-terminus.
- PTVs in the cardiac-specific M-motif were associated with earlier age-at-death (38 years) compared to C-terminal PTVs (57 and 67 years).
Findings:
- MYBPC3 PTVs are present in a subset of sudden unexpected cardiac death cases due to HCM.
- The location of PTVs within the MYBPC3 gene correlates with age at death, suggesting differential pathogenicity.
- Cardiac-specific M-motif PTVs appear to confer a more severe phenotype with earlier mortality in male carriers.
Implications:
- Understanding the impact of PTV location in MYBPC3 can refine risk stratification for HCM.
- This research highlights the importance of detailed genetic analysis in sudden cardiac death investigations.
- Further studies are warranted to elucidate the functional consequences of MYBPC3 PTV location on cardiac function and survival.
Abstract:
Our aim is to characterize predicted protein-truncating variants (PTVs) in MYBPC3, the gene most commonly associated with hypertrophic cardiomyopathy (HCM), found in a series of autopsied HCM cases after sudden unexpected cardiac death. All cases underwent death scene investigation, gross and microscopic autopsies, toxicological testing, a review of medical records, and a molecular analysis of 95 cardiac genes. We found four pathogenic PTVs in MYBPC3 among male decedents. All variants were previously submitted to ClinVar without phenotype details. Two PTVs were located in the cardiac-specific myosin S2-binding (M) motif at the N-terminus of the MYBPC3-encoded cMyBP-C protein, and two PTVs were in the non-cardiac-specific C-terminus of the protein. The carriers of two cardiac-specific M-motif PTVs died at age 38 years; their heart weight (HW, g) and body mass index (BMI, kg/m2) ratio were 34.90 (890/25.5) and 23.56 (980/41.6), respectively. In contrast, the carriers of two non-cardiac-specific C-terminal PTVs died at age 57 and 67 years, respectively; their HW and BMI ratio were 14.71 (450/30.6) and 13.98 (600/42.9), respectively. A detailed three-generation family study was conducted in one case. This study showed age-at-death variations among MYBPC3 PTVs carriers in adult males.
Related Concept Videos
Genetic Variation
Genes exist in different versions called alleles,...
Electron Carriers
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
The ADP/ATP Carrier Protein
Histone Variants at the Centromere
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...

